OAM
PTCT icon

OP Asset Management’s PTC Therapeutics PTCT Stock Holding History

OP Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Buy
33,602
+31,893
+1,866% +$2.26M 0.02% 414
2025
Q4 		$130K Hold
1,709
– – ﹤0.01% 746
2025
Q3 		$105K Sell
1,709
-9,614
-85% -$501K ﹤0.01% 761
2025
Q2 		$553K Buy
+11,323
New +$538K 0.01% 666

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

OP Asset Management's PTCT Position: Q1 2026 in Review

OP Asset Management increased its PTC Therapeutics (PTCT) stake by 1,866% in Q1 2026, buying an estimated $2.26M and bringing the position to 33,602 shares worth $2.29M. The position accounts for 0.02% of the portfolio, ranked #414.

OP Asset Management first reported a position in PTCT in Q2 2025 and has held it in 4 quarters since. 350 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • OP Asset Management held 33,602 shares of PTC Therapeutics worth $2.29M as of Q1 2026.
  • OP Asset Management bought 31,893 PTC Therapeutics shares in Q1 2026, an estimated $2.26M.
  • PTC Therapeutics made up 0.02% of OP Asset Management's portfolio in Q1 2026, its #414 holding.
  • OP Asset Management first reported a position in PTC Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.